MONROVIA, Calif., Jan. 8 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will present at the Needham & Company 10th Annual Growth Stock Conference on January 10, 2008 at the New York Palace Hotel. Barry G. Caldwell, STAAR Surgical's Chief Executive Officer, will discuss the Company's business strategy and historical financial performance at 7:30 a.m. Eastern Time.
Attendance at the conference is by invitation only. A live audio webcast of STAAR's presentation may be accessed through the Company's website at http://www.staar.com. An archived replay of the presentation will be available after the live presentation and can also be accessed at http://www.staar.com.
About STAAR Surgical
STAAR is a leader in the development, manufacture and marketing of
minimally invasive ophthalmic products employing proprietary technologies.
STAAR's products are used by ophthalmic surgeons and include the Visian
ICL, a tiny, flexible lens implanted to correct refractive errors, as well
as innovative products designed to improve patient outcomes for cataracts
and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by
the FDA for use in treating myopia, has received CE Marking and is sold in
more than 40 countries. More information is available at
CONTACT: Investors Media
EVC Group EVC Group
Douglas Sherk/Donald Takaya, Steve DiMattia,
|SOURCE STAAR Surgical Company|
Copyright©2008 PR Newswire.
All rights reserved